FTLF: FitLife Brands, Inc. Stock

by  •  • Comments Off on FTLF: FitLife Brands, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 127.00
Enterprise Value ($M) 145.87
Book Value ($M) 27.04
Book Value / Share 5.88
Price / Book 4.70
NCAV ($M) -13.62
NCAV / Share -2.96
Price / NCAV -9.33

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 0.54
Current Ratio 1.42

Balance Sheet (mrq) ($M)
Current Assets 14.69
Assets 55.35
Liabilities 28.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 52.70
Operating Income 9.50
Net Income 5.30
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 4.22
Cash from Investing -35.99
Cash from Financing 20.30

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-22 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPO
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-07 419 1,723 24.32
2024-05-06 1,997 3,550 56.25
2024-05-03 606 1,152 52.60
2024-05-02 45 322 13.98

(click for more detail)

Similar Companies
FBRX – Forte Biosciences, Inc. FENC – Fennec Pharmaceuticals Inc.
FLGC – Flora Growth Corp. FWBI – First Wave BioPharma, Inc.
GALT – Galectin Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io